Transparency data

CMA Board meeting minutes: 22 March 2023

Published 31 May 2023

Meeting date: 22 March 2023

Venue: In Tŷ William Morgan, Cardiff and by videoconference

Members present

• Marcus Bokkerink (Chair)
• Kirstin Baker
• Sarah Cardell (CEO)
• Martin Coleman
• Cynthia Dubin^{[footnote 1]}
• Amelia Fletcher
• Michael Grenfell
• Murdoch MacLennan^{[footnote 2]}
• David Stewart
• Erik Wilson (COO)

Advisors present

• Lucy Robbins, Senior Director, People, Capability and Culture
• Chris Prevett, Interim General Counsel
• Mike Walker, Chief Economic Adviser

Apologies

There were no apologies.

CMA staff present

• Kate Bridge, Director of Executive Office, Security and Performance
• Anthony Wright, Director of Communications^{[footnote 3]}
• Sukhinder Lalli, Legal Director, Governance, Compliance and Risk
• Chief of Staff, Executive Office
• Committee Secretary (minutes)

Teams

The meeting was attended by teams from across the CMA, including from Strategy, the Digital Markets Unit (DMU), People, Capability and Culture, and Remedies.

Minutes

Introduction

1 . Introduction

The Chair welcomed the Board members to the meeting.

Minutes

The Board approved the minutes from the meeting of the Board on 21 February 2023, without any changes. The Board acknowledged the committee minutes received.

2. Reflections on stakeholder engagement

The Board discussed the issues and feedback from their stakeholder roundtable and associated meetings the previous day.

Major developments in the external environment in which we operate

3 . CEO and Chair comments

The Board was updated on recent engagement with government.

Strategy, Policy, Portfolio and Risk Management

4 . CEO update

The CEO updated the Board on recent developments in the CMA. The Board reviewed the corporate risk register and the external guidance tracker.

5 . RPPC Update

The Board considered the outcomes of the March Resources, Portfolio and Pipeline meeting.

6 . CMA organisational resilience

The Board discussed the organisational risks and challenges to the CMA’s organisational resilience, agreeing the importance of having these risks in mind to inform future decision-making and providing guidance on possible mitigations.

7 . Audit and Risk Assurance Committee (ARAC) update

The Chair of the ARAC provided a summary of the recent ARAC meeting held on 20 March 2023.

8 . Annual report 2022 to 23

The Board endorsed the approach for the delivery of the 2022 to 23 Annual Report and Accounts and gave its views on the proposed headline structure and content.

9 . Digital Markets Unit update

The Board considered the monthly update on the work towards the DMU, reflecting on recent legislation and policy developments and endorsing the appointment of the Digital Experts; it noted that the CMA expects to use its expertise both on current cases and in DMU preparatory work.

10 . Remedies delivery portfolio

The Board was updated on the CMA’s recent work in remedies implementation, monitoring, enforcement and reviews of remedies. It highlighted the risks arising from some remedies and recommended possible mitigations.

11 . Creating an inclusive CMA Diversity and Inclusion Plan

The Board approved the Diversity and Inclusion Action Plan March 2023 to December 2024 for publication, noting that this will be published alongside the CMA’s Pay Gap report. It also reviewed and agreed the associated internal action plan noting that this contains a number of ‘accelerators’ to ensure resources are focused on the most effective areas to accelerate our efforts.

12 . AOB

The Chair reviewed the meeting and thanked the Board.

1. CD was recused from part of item 5 due to a previously declared conflict. ↩

2. MM joined from item 5. ↩

3. AW did not attend item 6. ↩